5-[(2,6-difluoro-3-methoxy-5-methylphenyl)methoxy]-N-(6-piperidin-4-yl-3-pyridinyl)pyrimidin-2-amine
C23H25F2N5O2 — CID 122605373
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[(2,6-difluoro-3-methoxy-5-methylphenyl)methoxy]-N-(6-piperidin-4-yl-3-pyridinyl)pyrimidin-2-amine
5-[(2,6-difluoro-3-methoxy-5-methylphenyl)methoxy]-N-(6-piperidin-4-yl-3-pyridinyl)pyrimidin-2-amine (PubChem CID 122605373) has the molecular formula C23H25F2N5O2 and a molecular weight of 441.48 g/mol. Its IUPAC name is 5-[(2,6-difluoro-3-methoxy-5-methylphenyl)methoxy]-N-(6-piperidin-4-yl-3-pyridinyl)pyrimidin-2-amine.
Molecular Properties
| Compound Name | 5-[(2,6-difluoro-3-methoxy-5-methylphenyl)methoxy]-N-(6-piperidin-4-yl-3-pyridinyl)pyrimidin-2-amine |
|---|---|
| PubChem CID | 122605373 |
| Molecular Formula | C23H25F2N5O2 |
| Molecular Weight | 441.48 g/mol |
| Exact Mass | 441.20 |
| IUPAC Name | 5-[(2,6-difluoro-3-methoxy-5-methylphenyl)methoxy]-N-(6-piperidin-4-yl-3-pyridinyl)pyrimidin-2-amine |
| SMILES | COc1cc(C)c(F)c(COc2cnc(Nc3ccc(C4CCNCC4)nc3)nc2)c1F |
| InChI | InChI=1S/C23H25F2N5O2/c1-14-9-20(31-2)22(25)18(21(14)24)13-32-17-11-28-23(29-12-17)30-16-3-4-19(27-10-16)15-5-7-26-8-6-15/h3-4,9-12,15,26H,5-8,13H2,1-2H3,(H,28,29,30) |
| InChIKey | SVEHHAOADNAGTL-UHFFFAOYSA-N |
| XLogP | 4.26 |
| TPSA | 81.19 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 441.48 |
| LogP ≤ 5 | 4.26 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122605373 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.